Karuna Therapeutics Inc. (KRTX) PT Raised to $131 at Goldman Sachs
Tweet
Share
E-mailGet Alerts KRTX Hot Sheet
Price: $329.83 --0%
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $131.00 (from $115.00) while maintaining a Buy rating.
You May Also Be Interested In
- QuantumScape (QS) PT Lowered to $6 at Truist Securities
- American International Group (AIG) PT Raised to $89 at Piper Sandler
- AvidBank Holdings Inc. (AVBH) PT Lowered to $23 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
